Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies

Main Category: Cancer / Oncology
Also Included In: Lymphoma / Leukemia / Myeloma;  Clinical Trials / Drug Trials
Article Date: 24 Jul 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Even after chemotherapies and stem cell transplants, relapses still occur in leukemia patients. This study established a mouse model after bone marrow transplant and found that the immunization of mice with leukemia-cell-derived heat shock protein 70 (HSP) induced leukemia-specific immunities and prolonged their survival.

The tumor-derived-HSP binds the tumor-specific antigenic peptides, making it an effective cancer vaccination. It has reported that patients with peptide-specific antibodies survived longer than those without.

Using leukemia-specific antibodies induced by HSP-based vaccination would be useful for the prognosis of leukemia and facilitate the establishment of novel therapeutic strategies in the future.

"Induction of leukemia-specific anti-bodies by immunotherapy with leukemia-cell-derived heat shock protein 70"
Junko Jimbo, Kazuya Sato, Takaaki Hosoki, Motohiro Shindo, Katsuya Ikuta, Yoshihiro Torimoto, Yutaka Kohgo
Cancer Science - Volume 99 Issue 7, Pages 1427 - 1434
10.1111/j.1349-7006.2008.00829.x
Click here to view Abstract online

About Cancer Science

Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer.

Subject categories include:
-- carcinogenesis
-- tumor biology and pathology
-- molecular biology and genetics
-- epidemiology and prevention
-- immunology and virology
-- experimental therapeutics
-- clinical medicine

www.blackwellpublishing.com/journal.asp?ref=1347-9032&site=1

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Cancer Science. "Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies." Medical News Today. MediLexicon, Intl., 24 Jul. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/115938.php>

APA
Cancer Science. (2008, July 24). "Immunotherapy With Leukemia-cell-derived Heat Shock Protein 70 Triggers Induction Of Leukemia-specific Antibodies." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/115938.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »